As Splunk (SPLK) Stock Declined, First Citizens Bank & Trust Co Has Lowered by $654,480 Its Holding; Emergent Biosolutions (EBS) Shareholder Public Sector Pension Investment Board Has Decreased Position as Share Value Rose

Emergent BioSolutions Inc. (NYSE:EBS) Logo

Public Sector Pension Investment Board decreased its stake in Emergent Biosolutions Inc (EBS) by 37.9% based on its latest 2018Q3 regulatory filing with the SEC. Public Sector Pension Investment Board sold 18,598 shares as the company’s stock rose 13.50% while stock markets declined. The institutional investor held 30,479 shares of the health care company at the end of 2018Q3, valued at $2.01 million, down from 49,077 at the end of the previous reported quarter. Public Sector Pension Investment Board who had been investing in Emergent Biosolutions Inc for a number of months, seems to be less bullish one the $3.35 billion market cap company. The stock increased 0.71% or $0.46 during the last trading session, reaching $65.66. About 324,271 shares traded. Emergent BioSolutions Inc. (NYSE:EBS) has risen 57.94% since February 14, 2018 and is uptrending. It has outperformed by 57.94% the S&P500. Some Historical EBS News: 26/03/2018 – Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company’s Growth Strategy; 26/03/2018 – EMERGENT BIOSOLUTIONS NAMES RICHARD S. LINDAHL EVP-CFO; 26/03/2018 – EMERGENT BIOSOLUTIONS INC – PROMOTED ROBERT G. KRAMER SR. TO NEWLY-CREATED POSITION OF PRESIDENT AND CHIEF OPERATING OFFICER; 12/04/2018 – Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries; 22/03/2018 – Emergent BioSolutions to Implement Stk Repurchase Program for Up to $50 M of Its Common Stk; 03/05/2018 – EMERGENT BIOSOLUTIONS INC EBS.N FY2018 SHR VIEW $2.38, REV VIEW $731.4 MLN — THOMSON REUTERS l/B/E/S; 21/04/2018 – DJ Emergent Capital Inc, Inst Holders, 1Q 2018 (EMGC); 18/05/2018 – Emergent, LLC Exclusively Awarded Small Business DoD Enterprise Software Initiative Contract To Provide Red Hat Solutions; 31/05/2018 – SPROTT INVESTS IN EMERGENT TECHNOLOGY HOLDINGS; 26/03/2018 – EMERGENT BIOSOLUTIONS INC – APPOINTED RICHARD S. LINDAHL AS COMPANY’S NEW EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

First Citizens Bank & Trust Co decreased its stake in Splunk Inc (SPLK) by 40.13% based on its latest 2018Q3 regulatory filing with the SEC. First Citizens Bank & Trust Co sold 5,454 shares as the company’s stock declined 13.50% with the market. The hedge fund held 8,138 shares of the prepackaged software company at the end of 2018Q3, valued at $984,000, down from 13,592 at the end of the previous reported quarter. First Citizens Bank & Trust Co who had been investing in Splunk Inc for a number of months, seems to be less bullish one the $19.78B market cap company. The stock decreased 0.34% or $0.46 during the last trading session, reaching $133.81. About 877,314 shares traded. Splunk Inc. (NASDAQ:SPLK) has risen 34.57% since February 14, 2018 and is uptrending. It has outperformed by 34.57% the S&P500. Some Historical SPLK News: 17/04/2018 – Splunk Congratulates FCW Federal 100 Award Winner from U.S. Department of Health and Human Services; 28/03/2018 – SPLUNK INC SPLK.O : WEDBUSH RAISES TARGET PRICE TO $103 FROM $101; 24/05/2018 – SPLUNK INC SPLK.O SEES FY 2019 REVENUE ABOUT $1.645 BLN; 22/04/2018 – DJ Splunk Inc, Inst Holders, 1Q 2018 (SPLK); 24/05/2018 – SPLUNK SEES 2Q REV. $356M TO $358M, EST. $354.8M; 12/03/2018 – “Mad Money” host Jim Cramer sits down with Splunk President and CEO Doug Merritt for the latest on his analytics company’s disruptive story; 16/05/2018 – tCell Joins Splunk Adaptive Response Initiative; 24/05/2018 – Splunk Sees 2Q Rev $356M-$358M; 24/05/2018 – Splunk 1Q Rev $311.6M; 25/05/2018 – SPLUNK INC SPLK.O : UBS RAISES TARGET PRICE TO $133 FROM $114

Among 48 analysts covering Splunk Inc (NASDAQ:SPLK), 39 have Buy rating, 1 Sell and 8 Hold. Therefore 81% are positive. Splunk Inc had 216 analyst reports since August 24, 2015 according to SRatingsIntel. JP Morgan maintained Splunk Inc. (NASDAQ:SPLK) rating on Monday, March 5. JP Morgan has “Neutral” rating and $100 target. Stifel Nicolaus maintained the stock with “Hold” rating in Monday, July 24 report. On Friday, October 9 the stock rating was initiated by Drexel Hamilton with “Buy”. As per Friday, May 27, the company rating was maintained by Deutsche Bank. RBC Capital Markets maintained the shares of SPLK in report on Friday, August 19 with “Outperform” rating. The firm has “Buy” rating by FBN Securities given on Friday, November 17. The rating was maintained by JMP Securities with “Market Outperform” on Friday, May 25. The rating was maintained by Maxim Group with “Buy” on Thursday, July 21. Canaccord Genuity maintained it with “Buy” rating and $80 target in Friday, August 25 report. The company was maintained on Friday, August 24 by Stifel Nicolaus.

Since September 10, 2018, it had 0 insider buys, and 18 insider sales for $20.50 million activity. Tully Timothy sold $264,811 worth of Splunk Inc. (NASDAQ:SPLK) on Monday, December 10. 10,714 shares valued at $1.34 million were sold by STEIN LEONARD R on Tuesday, September 11. CONTE DAVID F had sold 15,519 shares worth $1.94 million. St. Ledger Susan sold 40,787 shares worth $5.09 million. 23,572 Splunk Inc. (NASDAQ:SPLK) shares with value of $2.94M were sold by Merritt Douglas. The insider Carges Mark T sold $261,103.

Analysts await Splunk Inc. (NASDAQ:SPLK) to report earnings on March, 7. They expect $0.20 EPS, up 281.82% or $0.31 from last year’s $-0.11 per share. SPLK’s profit will be $29.56 million for 167.26 P/E if the $0.20 EPS becomes a reality. After $-0.22 actual EPS reported by Splunk Inc. for the previous quarter, Wall Street now forecasts -190.91% EPS growth.

Investors sentiment decreased to 1.28 in 2018 Q3. Its down 0.07, from 1.35 in 2018Q2. It fall, as 32 investors sold SPLK shares while 141 reduced holdings. 94 funds opened positions while 128 raised stakes. 125.54 million shares or 0.80% less from 126.55 million shares in 2018Q2 were reported. Moreover, Macquarie Group Inc has 0.1% invested in Splunk Inc. (NASDAQ:SPLK). Sandler Cap Management reported 87,303 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.04% of its portfolio in Splunk Inc. (NASDAQ:SPLK) for 42,509 shares. Comerica Incorporated holds 4,847 shares or 0.07% of its portfolio. Whittier Trust Com Of Nevada holds 0% or 35 shares. Natixis accumulated 159,974 shares or 0.11% of the stock. Cambridge owns 6,482 shares. Royal Fincl Bank Of Canada invested 0% of its portfolio in Splunk Inc. (NASDAQ:SPLK). Moreover, Gofen & Glossberg Il has 0.11% invested in Splunk Inc. (NASDAQ:SPLK). Manufacturers Life Insur The has invested 0% in Splunk Inc. (NASDAQ:SPLK). Moreover, Bancorp Of New York Mellon has 0.13% invested in Splunk Inc. (NASDAQ:SPLK) for 4.16M shares. First Hawaiian Commercial Bank accumulated 7,210 shares or 0.05% of the stock. Symmetry Peak Ltd Liability invested in 1.63% or 38,200 shares. 12,472 are owned by Quantbot Techs Lp. Baystate Wealth Ltd holds 50 shares.

First Citizens Bank & Trust Co, which manages about $900.33 million US Long portfolio, upped its stake in Veeva Sys Inc (NYSE:VEEV) by 6,227 shares to 15,793 shares, valued at $1.72 million in 2018Q3, according to the filing. It also increased its holding in Darden Restaurants Inc (NYSE:DRI) by 4,423 shares in the quarter, for a total of 8,448 shares, and has risen its stake in Ishares Tr (IEUR).

More notable recent Splunk Inc. (NASDAQ:SPLK) news were published by: Investorplace.com which released: “5 Terrific Tech Stocks That Will Make You Forget About FANG – Investorplace.com” on January 24, 2019, also Nasdaq.com with their article: “Splunk (SPLK) Q3 Earnings and Revenues Top Estimates – Nasdaq” published on November 29, 2018, Nasdaq.com published: “Splunk (SPLK) Q3 Earnings to Benefit From Portfolio Strength – Nasdaq” on November 26, 2018. More interesting news about Splunk Inc. (NASDAQ:SPLK) were released by: Zacks.com and their article: “Is Splunk (SPLK) Outperforming Other Computer and Technology Stocks This Year? – Zacks.com” published on January 15, 2019 as well as Seekingalpha.com‘s news article titled: “Splunk reports Q3 beats, raises FY19 and 20 guidance – Seeking Alpha” with publication date: November 29, 2018.

Public Sector Pension Investment Board, which manages about $14.28 billion US Long portfolio, upped its stake in Progressive Corp Ohio (NYSE:PGR) by 83,900 shares to 116,367 shares, valued at $8.27 million in 2018Q3, according to the filing. It also increased its holding in Canadian Nat Res Ltd (NYSE:CNQ) by 478,214 shares in the quarter, for a total of 4.45 million shares, and has risen its stake in Shaw Communications Inc (NYSE:SJR).

Analysts await Emergent BioSolutions Inc. (NYSE:EBS) to report earnings on February, 28. They expect $0.54 EPS, down 27.03% or $0.20 from last year’s $0.74 per share. EBS’s profit will be $27.51 million for 30.40 P/E if the $0.54 EPS becomes a reality. After $0.55 actual EPS reported by Emergent BioSolutions Inc. for the previous quarter, Wall Street now forecasts -1.82% negative EPS growth.

Since September 4, 2018, it had 0 insider buys, and 12 selling transactions for $17.89 million activity. 314 shares were sold by Havey Adam, worth $19,311. 7,893 shares were sold by Richard Ronald, worth $552,510. Bailey Sue also sold $1.23 million worth of Emergent BioSolutions Inc. (NYSE:EBS) shares. Abdun-Nabi Daniel sold $5.46 million worth of stock or 90,776 shares. Harsanyi Zsolt had sold 8,000 shares worth $551,194 on Tuesday, November 6. On Wednesday, November 7 Zoon Kathryn C sold $295,856 worth of Emergent BioSolutions Inc. (NYSE:EBS) or 4,242 shares.

More notable recent Emergent BioSolutions Inc. (NYSE:EBS) news were published by: Globenewswire.com which released: “Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax – GlobeNewswire” on August 13, 2018, also Globenewswire.com with their article: “Emergent BioSolutions to Offer All Public Libraries and YMCAs in the U.S. Free Opioid Awareness Education and NARCANĀ® (naloxone HCl) Nasal Spray – GlobeNewswire” published on October 24, 2018, Globenewswire.com published: “Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months of 2018 – GlobeNewswire” on August 02, 2018. More interesting news about Emergent BioSolutions Inc. (NYSE:EBS) were released by: Globenewswire.com and their article: “Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire as CEO; Robert G. Kramer, Sr. to Become President and CEO – GlobeNewswire” published on January 04, 2019 as well as Seekingalpha.com‘s news article titled: “Emergent Bio’s Zika vaccine shows positive action in early-stage study – Seeking Alpha” with publication date: November 19, 2018.

Among 7 analysts covering Emergent Biosolutions (NYSE:EBS), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Emergent Biosolutions had 16 analyst reports since August 10, 2015 according to SRatingsIntel. Cantor Fitzgerald initiated the stock with “Buy” rating in Monday, June 11 report. The firm has “Buy” rating by Chardan Capital Markets given on Tuesday, September 4. On Monday, August 10 the stock rating was upgraded by Zacks to “Hold”. The firm earned “Hold” rating on Tuesday, April 24 by Wells Fargo. The firm has “Overweight” rating given on Friday, November 2 by Cantor Fitzgerald. As per Thursday, August 30, the company rating was maintained by Wells Fargo. The rating was maintained by Cowen & Co on Friday, July 14 with “Hold”. Singular Research maintained Emergent BioSolutions Inc. (NYSE:EBS) on Tuesday, February 27 with “Buy” rating. The firm earned “Buy” rating on Monday, March 28 by Singular Research. Wells Fargo initiated the stock with “Outperform” rating in Friday, February 19 report.

Investors sentiment increased to 1.12 in 2018 Q3. Its up 0.12, from 1 in 2018Q2. It is positive, as 15 investors sold EBS shares while 84 reduced holdings. 42 funds opened positions while 69 raised stakes. 38.83 million shares or 1.86% more from 38.12 million shares in 2018Q2 were reported. Geode Capital Ltd Liability Corporation reported 0.01% stake. Alliancebernstein Lp holds 126,780 shares. Hotchkis & Wiley Mgmt Ltd owns 47,548 shares. Zebra Management Ltd Liability holds 0.14% or 4,697 shares. Kepos Cap Ltd Partnership has invested 0.16% in Emergent BioSolutions Inc. (NYSE:EBS). The Montana-based Da Davidson & Com has invested 0% in Emergent BioSolutions Inc. (NYSE:EBS). 1.89 million are held by State Street. The Minnesota-based Us Financial Bank De has invested 0% in Emergent BioSolutions Inc. (NYSE:EBS). Massachusetts-based Woodstock has invested 0.12% in Emergent BioSolutions Inc. (NYSE:EBS). Teachers Retirement Sys Of The State Of Kentucky stated it has 0.01% in Emergent BioSolutions Inc. (NYSE:EBS). Fdx Advsr has 0.02% invested in Emergent BioSolutions Inc. (NYSE:EBS) for 9,793 shares. Eam Investors Llc reported 0.54% stake. American Intll Group holds 0.01% or 34,877 shares in its portfolio. 41,799 are owned by Sio Cap Ltd Liability Corporation. 104,401 were accumulated by Rhumbline Advisers.

Splunk Inc. (NASDAQ:SPLK) Institutional Positions Chart